Human insulin allergy-immediate and late type III reactions in a long-standing IDDM patient-Reference-Cited by-同舟云学术

Human insulin allergy-immediate and late type III reactions in a long-standing IDDM patient

Published:1997-05 Issue:2 Volume:36 Page:67-70
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Silva Maria E.R.,Mendes Maria J.M.,Ursich Mileni J.M.,Rocha Dalva M.,Brito Alberto H.M.,Fukui Rosa T.,Ruggeri Gláucia B.,Nery Marcia,Wajchenberg Bernardo L.

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference7 articles.

1. Chemistry and Clinical Use of Insulin;Galloway,1988

2. Hemoglobin components in patients with diabetes mellitus;Trivelli;N. Engl. J. Med.,1971

3. Competitive Insulin Autoantibody Assay. Prospective Evaluation of Subjects at High Risk for Development of Type I Diabetes Mellitus;Vardi;Diabetes,1987

4. Systematic approach to diagnosis and management of biphasic insulin allergy with local anti-inflammatory agents;Loeb;Diabetes Care,1989

5. Immunogenicity and allergenic potential of animal and human insulins;Schernthaner;Diabetes Care,1993

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A case report and systematic literature review: insulin-induced type III hypersensitivity reaction;Frontiers in Allergy;2024-02-21

2. Injection Site Reaction to Various Insulins as Type III Allergy With Urticarial Vasculitis in a Patient With Type I Diabetes Mellitus;The American Journal of Dermatopathology;2022-12-07

3. Insulin Allergy to Detemir Followed by Rapid Onset of Diabetic Ketoacidosis: A Case Report and Literature Review;Frontiers in Endocrinology;2022-03-08

4. Practical Guidance for the Evaluation and Management of Drug Hypersensitivity: Specific Drugs;The Journal of Allergy and Clinical Immunology: In Practice;2020-10

5. Ambulatory intravenous insulin and islet cell transplantation to treat severe type III insulin hypersensitivity in a patient with type 1 diabetes mellitus;Clinical Case Reports;2020-08-30